Cleared Traditional

K981109 - QUITETIP

K981109 is an FDA 510(k) clearance for QUITETIP, manufactured by Paradigm Medical Industries, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 74-day FDA review.

K981109 · Paradigm Medical Industries, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1998
Decision
74d
Days
Class 2
Risk

K981109 is an FDA 510(k) clearance for the QUITETIP. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Paradigm Medical Industries, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on June 9, 1998 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Paradigm Medical Industries, Inc. devices

FDA 510(k) Submission Details - K981109

510(k) Number K981109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 1998
Decision Date June 09, 1998
Days to Decision 74 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 110d · This submission: 74d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 160
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K981109.
SURGE-FREE ASPIRATION ADAPTER
K020734 · Staar Surgical Co. · May 2002
MOJAVE CATARACT EXTRACTION SYSTEM
K003638 · Allergan, Inc. · Feb 2001
TURBOSONICS LIMITED REUSE ULTRASONIC TIP
K981103 · Alcon Laboratories · Jun 1998
MENTOR PHACOEMULSIFICATION SISTEM REMOTE CONTROL
K974469 · Mentor Corp. · Feb 1998
FRAG COMMANDER
K973749 · Scieran Technologies, Inc. · Dec 1997
WHITTINGHAM ULTRACLEAN PHACO HANDPIECE
K972063 · William F. Whittingham · Nov 1997